SIRT6: therapeutic target for nonalcoholic fatty liver disease

Mengwei Zang, Bin Gao

Research output: Contribution to journalShort surveypeer-review

1 Scopus citations


Recently, Hou et al. shifted the research focus from the function of nuclear sirtuin (SIRT)6 to that of cytoplasmic SIRT6, which deacetylates and activates long-chain acyl-CoA synthase 5 (ACSL5). Their findings provide mechanistic insight into the role of cytoplasmic SIRT6 in fatty acid oxidation, acting as a therapeutic target for combating nonalcoholic fatty liver disease (NAFLD).

Original languageEnglish (US)
Pages (from-to)801-803
Number of pages3
JournalTrends in Endocrinology and Metabolism
Issue number12
StatePublished - Dec 2022


  • SIRT6
  • deacetylation
  • fatty acid oxidation
  • lipid metabolism
  • long-chain acyl-CoA synthase 5
  • nonalcoholic fatty liver disease

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'SIRT6: therapeutic target for nonalcoholic fatty liver disease'. Together they form a unique fingerprint.

Cite this